Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Child's Nervous System
Published in: Child's Nervous System 8-9/2005

01-08-2005 | Special Annual Issue

Endocrine manifestations of craniopharyngioma

Authors: Isil Halac, Donald Zimmerman

Published in: Child's Nervous System | Issue 8-9/2005

Login to get access

Abstract

Rationale

Due to the proximity of craniopharyngiomas to the hypothalamus and pituitary gland, most children and adolescents presenting with these tumors will exhibit significant endocrine dysfunction. After treatment, these impairments can become a major cause of morbidity and mortality.

Methods

The postoperative course of children undergoing surgery for craniopharyngioma is reviewed.

Conclusion

Even if hormone levels seem to be adequate in the short term after treatment, deficiencies may develop over years and need to be monitored closely.
Literature
1.
Chakrabarty A, Mitchell P, Bridges LR (1998) Craniopharyngioma invading the nasal and paranasal spaces, and presenting as nasal obstruction. Br J Neurosurg 12(4):361–363CrossRefPubMed
2.
Sklar CA (1994) Craniopharyngioma: endocrine abnormalities at presentation. Pediatr Neurosurg 21(Suppl 1):18–20PubMed
3.
Robinson AG, Verbalis JG (2003) Posterior pituitary gland. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS (eds) Williams textbook of endocrinology. Elsevier Science, Philadelphia, PA, pp 281–329
4.
Banna M, Hoare RD, Stanley P, Till K (1973) Craniopharyngioma in children. J Pediatr 83(5):781–785PubMed
5.
de Vries L, Lazar L, Phillip M (2003) Craniopharyngioma: presentation and endocrine sequelae in 36 children. J Pediatr Endocrinol Metab 16(5):110–703PubMed
6.
Thomsett MJ, Conte FA, Kaplan SL, Grumbach MM (1980) Endocrine and neurologic outcome in childhood craniopharyngioma: review of effect of treatment in 42 patients. J Pediatr 97(5):728–735PubMed
7.
Sorva R (1988) Children with craniopharyngioma. Early growth failure and rapid postoperative weight gain. Acta Paediatr Scand 77(4):587–592PubMed
8.
Wit JM, Schuitema-Dijkstra A, van Buul-Offers S, Opmeer F, Van den Brande JL (1988) Excessive growth in a child with craniopharyngioma and growth hormone deficiency. Eur J Pediatr 147(6):658–661CrossRefPubMed
9.
Blethen SL, Weldon VV (1986) Outcome in children with normal growth following removal of a craniopharyngioma. Am J Med Sci 292(1):21–24PubMed
10.
Weinzimer SA, Homan SA, Ferry RJ, Moshang T (1999) Serum IGF-I and IGFBP-3 concentrations do not accurately predict growth hormone deficiency in children with brain tumours. Clin Endocrinol (Oxf) 51(3):339–345CrossRef
11.
Moshang T Jr, Rundle AC, Graves DA, Nickas J, Johanson A, Meadows A (1996) Brain tumor recurrence in children treated with growth hormone: the National Cooperative Growth Study experience. J Pediatr 128(5 Pt 2):S4–S7PubMed
12.
Wilton P, Price DA (1992) Rate of relapse of craniopharyngioma in children treated with growth hormone. KIGS Biannu Rep No 8 1:48–54
13.
Niu DM, Guo WY, Pan HC, Wong TT (2002) Rapid enlargement of a residual craniopharyngioma during short-term growth hormone replacement. Childs Nerv Syst 18(3–4):164–165. Epub 2002 Mar 5CrossRefPubMed
14.
15.
Lustig RH, Post SR, Srivannaboon K, Rose SR, Danish RK, Burghen GA, Xiong X, Wu S, Merchant TE (2003) Risk factors for the development of obesity in children surviving brain tumors. J Clin Endocrinol Metab 88(2):611–616CrossRefPubMed
16.
Muller HL, Emser A, Faldum A, Bruhnken G, Etavard-Gorris N, Gebhardt U, Oeverink R, Kolb R, Sorensen N (2004) Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma. J Clin Endocrinol Metab 89(7):3298–3305CrossRefPubMed
17.
Attia N, Tamborlane WV, Heptulla R, Maggs D, Grozman A, Sherwin RS, Caprio S (1998) The metabolic syndrome and insulin-like growth factor I regulation in adolescent obesity. J Clin Endocrinol Metab 83(5):1467–1471CrossRefPubMed
18.
Schoenle EJ, Zapf J, Prader A, Torresani T, Werder EA, Zachmann M (1995) Replacement of growth hormone (GH) in normally growing GH-deficient patients operated for craniopharyngioma. J Clin Endocrinol Metab 80(2):374–378CrossRefPubMed
19.
Pajas M, Lucas T, Garcia-Uria J, Salame F, Barcelo B, Estrada J (1995) Hypothalamic–pituitary dysfunction in patients with craniopharyngioma. Clin Endocrinol (Oxf) 42(5):467–473
20.
Clopper RR, Mazur T, MacGillivray MH, Peterson RE, Voorhess ML (1983) Data on virilization and erotosexual behavior in male hypogonadotropic hypopituitarism during gonadotropin and androgen treatment. J Androl 4(5):303–311PubMed
21.
Abbaticchio G, Micale FM, Giagulli VA, Giorgino R (1985) Recovery of fertility in a hypogonadotropic man apparently resistant to gonadotrophin treatment. Arch Androl 15(1):59–64PubMed
22.
Volz J, Heinrich U, Volz-Koster S (2002) Conception and spontaneous delivery after total hypophysectomy. Fertil Steril 77(3):624–625CrossRefPubMed
23.
Hayashi M, Tomobe K, Hoshimoto K, Ohkura T (2002) Successful pregnancy following gonadotropin therapy in a patient with hypogonadotropic hypogonadism resulting from craniopharyngioma. Int J Clin Pract 56(2):149–151PubMed
24.
Zachmann M, Illig R (1979) Precocious puberty after surgery for craniopharyngioma. J Pediatr 95(1):86–88PubMed
25.
Persani L, Ferretti E, Borgato S, Faglia G, Beck-Peccoz P (2000) Circulating thyrotropin bioactivity in sporadic central hypothyroidism. J Clin Endocrinol Metab 85(10):3631–3635CrossRefPubMed
26.
Gruneiro-Papendieck L, Chiesa A, Martinez A, Heinrich JJ, Bergada C (1998) Nocturnal TSH surge and TRH test response in the evaluation of thyroid axis in hypothalamic pituitary disorders in childhood. Horm Res 50(5):252–257CrossRefPubMed
27.
Bin-Abbas B, Mawlawi H, Sakati N, Khafaja Y, Chaudhary MA, Al-Ashwal A (2001) Endocrine sequelae of childhood craniopharyngioma. J Pediatr Endocrinol Metab 14(7):869–874PubMed
28.
Isojarvi JI, Turkka J, Pakarinen AJ, Kotila M, Rattya J, Myllyla VV (2001) Thyroid function in men taking carbamazepine, oxcarbazepine, or valproate for epilepsy. Epilepsia 42(7):930–934CrossRefPubMed
29.
Surks MI, DeFesi CR (1996) Normal serum free thyroid hormone concentrations in patients treated with phenytoin or carbamazepine. A paradox resolved. JAMA 275(19):1495–1498CrossRefPubMed
30.
Lyen KR, Grant DB (1982) Endocrine function, morbidity, and mortality after surgery for craniopharyngioma. Arch Dis Child 57(11):837–841PubMed
31.
Rose SR, Danish RK, Kearney NS, Schreiber RE, Lustig RH, Burghen GA, Hudson MM (2005) ACTH deficiency in childhood cancer survivors. Pediatr Blood Cancer, Feb 7
32.
Styne DM, Richards GE, Bell JJ et al (1977) Growth patterns in congenital adrenal hyperplasia: correlation of glucocorticoid therapy with stature. In: Lee P, Plotnick L, Kowarski A, Migeon C (eds) Congenital adrenal hyperplasia. University Park Press, Baltimore, pp 247–261
33.
Linder BL, Esteban NV, Yergey AL, Winterer JC, Loriaux DL, Cassorla F (1990) Cortisol production rate in childhood and adolescence. J Pediatr 117(6):892–896PubMed
34.
Kerrigan JR, Veldhuis JD, Leyo SA, Iranmanesh A, Rogol AD (1993) Estimation of daily cortisol production and clearance rates in normal pubertal males by deconvolution analysis. J Clin Endocrinol Metab 76(6):1505–1510CrossRefPubMed
35.
Miller WL (2003) The adrenal cortex. In: Sperling MA (ed) Pediatric endocrinology. Elsevier Science, Philadelphia, PA pp 385–438
36.
Lehrnbecher T, Muller-Scholden J, Danhauser-Leistner I, Sorensen N, von Stockhausen HB (1998) Perioperative fluid and electrolyte management in children undergoing surgery for craniopharyngioma. A 10-year experience in a single institution. Childs Nerv Syst 14(6):276–279CrossRefPubMed
37.
Gonzales-Portillo G, Tomita T (1998) The syndrome of inappropriate secretion of antidiuretic hormone: an unusual presentation for childhood craniopharyngioma: report of three cases. Neurosurgery 42(4):917–921; discussion 921–922CrossRefPubMed
38.
Hetelekidis S, Barnes PD, Tao ML, Fischer EG, Schneider L, Scott RM, Tarbell NJ (1993) 20-year experience in childhood craniopharyngioma. Int J Radiat Oncol Biol Phys 27(2):189–195PubMed
39.
Jeanrenaud B (1985) An hypothesis on the aetiology of obesity: dysfunction of the central nervous system as a primary cause. Diabetologia 28(8):502–513 ReviewCrossRefPubMed
40.
Bray GA, York DA (1979) Hypothalamic and genetic obesity in experimental animals: an autonomic and endocrine hypothesis. Physiol Rev 59(3):719–809PubMed
41.
Smith DK, Sarfeh J, Howard L (1983) Truncal vagotomy in hypothalamic obesity. Lancet 1(8337):1330–1331CrossRefPubMed
42.
Lustig RH, Rose SR, Burghen GA, Velasquez-Mieyer P, Broome DC, Smith K, Li H, Hudson MM, Heideman RL, Kun LE (1999) Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonist. J Pediatr 135(2 Pt 1):162–168PubMed
43.
Mason PW, Krawiecki N, Meacham LR (2002) The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma. Arch Pediatr Adolesc Med 156(9):887–892PubMed
44.
Larijani B, Bastanhagh MH, Pajouhi M, Kargar Shadab F, Vasigh A, Aghakhani S (2004) Presentation and outcome of 93 cases of craniopharyngioma. Eur J Cancer Care (Engl) 13(1):11–15CrossRef
45.
Sorva R, Heiskanen O, Perheentupa J (1988) Craniopharyngioma surgery in children: endocrine and visual outcome. Childs Nerv Syst 4(2):97–99PubMed
46.
Nakasu Y, Nakasu S, Handa J, Takeuchi J (1980) Amenorrhea–galactorrhea syndrome with craniopharyngioma. Surg Neurol 13(2):154–156PubMed
47.
Muller HL, Handwerker G, Wollny B, Faldum A, Sorensen N (2002) Melatonin secretion and increased daytime sleepiness in childhood craniopharyngioma patients. J Clin Endocrinol Metab 87(8):3993–3996CrossRefPubMed
48.
Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC, Stewart PM (2001) Association between premature mortality and hypopituitarism. West midlands prospective hypopituitary study group. Lancet 357(9254):425–431CrossRefPubMed
Metadata
Title
Endocrine manifestations of craniopharyngioma
Authors
Isil Halac
Donald Zimmerman
Publication date
01-08-2005
Publisher
Springer-Verlag
Published in
Child's Nervous System / Issue 8-9/2005
Print ISSN: 0256-7040
Electronic ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-005-1246-x

Other articles of this Issue 8-9/2005

Child's Nervous System 8-9/2005 Go to the issue

Special Annual Issue

Intracavitary therapeutic options in the management of cystic craniopharyngioma

Special Annual Issue

Craniopharyngioma: a personal (Boston) experience

Special Annual Issue

Long-term outcome and reconsideration of intracystic chemotherapy with bleomycin for craniopharyngioma in children

Special Annual Issue

The pathogenesis of craniopharyngiomas

Special Annual Issue

Craniopharyngioma: the pendulum of surgical management

Special Annual Issue

Radical resection of craniopharyngioma